FindTrial
Sign In

Diagnostic Utility of Platelet Count/Lymphocyte Count Ratio and Platelet Count/Mean Platelet Volume Ratio in Periprosthetic Joint Infection Following Total Knee Arthroplasty

Diagnostic Utility of Platelet Count/Lymphocyte Count Ratio and Platelet Count/Mean Platelet Volume Ratio in Periprosthetic Joint Infection Following Total Knee Arthroplasty

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000038286
Enrollment
Unknown
Registered
2020-09-16
Start date
2020-09-15
Completion date
Unknown
Last updated
2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee disease

Interventions

Count/Mean&#32
Volume&#32
in&#32
Periprosthetic&#32
Joint&#32
Infection&#32
Following&#32
Total&#32
Knee&#32
Arthroplasty
Ratio&#32
and&#32
Platelet&#32
Gold Standard:Clinical outcome.
Index test:Platelet&#32
Count/Lymphocyte&#32
Count&#32

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients with hip arthroplasty; 2. Patients with normal mental state can cooperate with functional exercise; 3. Patients' informed consent to the treatment and trial plan.

Exclusion criteria

Exclusion criteria: 1. Patients with coagulation dysfunction before operation; 2. Patients with previous DVT history; 3. Patients with long-term oral contraceptives 4. Patients with history of infection and tumor.

Design outcomes

Primary

MeasureTime frame
platelet/lymphocyte ratio;platelet/mean platelet volume ratio;SEN, SPE, ACC, AUC of ROC, PPV, NPV;—

Countries

China

Contacts

Public ContactFeng Shuo

Affiliated Hospital of Xuzhou Medical University

781733181@qq.com+86 18552880088

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026